Feline orofacial pain syndrome (FOPS): A retrospective study of 113 cases

Journal of Feline Medicine and Surgery

Volumn 12, Issue 6, 2010, Pages 498-508

  Rusbridge, Clare ^a   Heath, Sarah ^b   Gunn Moore, Danièlle A ^c   Knowler, Susan Penelope ^a   Johnston, Norman ^d   McFadyen, Angus Kennedy ^e  

^a Stone Lion Veterinary Centre   (United Kingdom)

^b Behavioural Referrals Veterinary Practice   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d DentalVets   (United Kingdom)

^e GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; FACE PAIN; FEMALE; MALE; MOUTH; MOUTH DISEASE; PATHOLOGY; PEDIGREE; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

ANALGESICS; ANIMALS; CAT DISEASES; CATS; FACIAL NEURALGIA; FEMALE; MALE; MOUTH; MOUTH DISEASES; PEDIGREE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

FELIDAE;

EID: 77953081316     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2010.03.005     Document Type: Article

References (60)

1. Roche G.M. Irritation from erupting teeth. Vet Rec 1994, 134:360.
2. Heath S., Rusbridge C., Johnson N., Gunn-Moore D. Orofacial pain syndrome in cats. Vet Rec 2001, 149:660.
3. Rusbridge C., Heath S.E., Johnson N.W., Gunn-Moore D.A. Feline orofacial pain syndrome. J Vet Intern Med 2002, 17:246.
4. Woolf C.J., Salter M.W. Neuronal plasticity: increasing the gain in pain. Science 2000, 288:1765-1788.
5. Costigan M., Woolf C.J. Pain: molecular mechanisms. J Pain 2000, 1(3 suppl):35-44.
6. Stein C., Clark J.D., Oh U., et al. Peripheral mechanisms of pain and analgesia. Brain Res Rev 2009, 60:90-113.
7. Coste J., Voisin D.L., Miraucourt L.S., Dallel R., Luccarini P. Dorsal horn NK1-expressing neurons control windup of downstream trigeminal nociceptive neurons. Pain 2008, 137:340-351.
8. Yaksh T.L. Behavioral and anatomic correlates of the tactile-evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists. Pain 1989, 37:111-123.
9. Neumann S., Doubell T.P., Leslie T., Woolf C.J. Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature 1996, 384:360-364.
10. Lommer M.J., Verstraete F.J. Radiographic patterns of periodontitis in cats: 147 cases (1998-1999). J Am Vet Med Assoc 2001, 218:230-234.
11. Love S., Coakham H.B. Trigeminal neuralgia: pathology and pathogenesis. Brain 2001, 124:2347-2360.
12. Marbach J.J. Medically unexplained chronic orofacial pain. Temporomandibular pain and dysfunction syndrome, orofacial phantom pain, burning mouth syndrome and trigeminal neuralgia. Med Clin North Am 1999, 83:691-710.
13. Reiss M., Reiss G. Burning mouth syndrome-etiology, differential diagnostical aspects and therapy. Ther Umsch 2004, 61:308-312.
14. Pinto A., Stoopler E.T., DeRossi S.S., Sollecito T.P., Popovic R. Burning mouth syndrome: a guide for the general practitioner. Gen Dent 2003, 51:458-461.
15. Muzyka B.C., De Rossi S.S. A review of burning mouth syndrome. Cutis 1999, 64:29-35.
16. Braga F.M., Bonatelli A.D., Suriano I., Canteras M. Familial trigeminal neuralgia. Surg Neurol 1986, 26:405-408.
17. Coffey R.J., Fromm G.H. Familial trigeminal neuralgia and Charcot-Marie-Tooth neuropathy. Report of two families and review. Surg Neurol 1991, 35:49-53.
18. Fleetwood I.G., Innes A.M., Hansen S.R., Steinberg G.K. Familial trigeminal neuralgia. Case report and review of the literature. J Neurosurg 2001, 95:513-517.
19. Kirkpatrick D.B. Familial trigeminal neuralgia: case report. Neurosurgery 1989, 24:758-761.
20. Miyaoka H., Kamijima K., Katayama Y., Ebihara T., Nagai T. A psychiatric appraisal of 'glossodynia'. Psychosomatics 1996, 37:346-348.
21. Eli I., Baht R., Littner M.M., Kleinhauz M. Detection of psychopathologic trends in glossodynia patients. Psychosom Med 1994, 56:389-394.
22. Kuĝu N., Akyüz G., Doĝan O. Burning mouth syndrome and depression: a case report. Turk Psikiyatri Derg 2002, 13:232-237.
23. Vissers K., De Jongh R., Hoffmann V., Heylen R., Crul B., Meert T. Internal and external factors affecting the development of neuropathic pain in rodents. Is it all about pain?. Pain Pract 2003, 3:326-342.
24. Maletic V., Raison C.L. Neurobiology of depression, fibromyalgia and neuropathic pain. Front Biosci 2009, 14:5291-5338.
25. Cashmore R.G., Harcourt-Brown T.R., Freeman P.M., Jeffery N.D., Granger N. Clinical diagnosis and treatment of suspected neuropathic pain in three dogs. Aust Vet J 2009, 87:45-50.
26. Mathews K.A. Neuropathic pain in dogs and cats: if only they could tell us if they hurt. Vet Clin North Am Small Anim Pract 2008, 38:1365-1414.
27. Rusbridge C., Jeffery N.D. Pathophysiology and treatment of neuropathic pain associated with syringomyelia. Vet J 2008, 175:164-172.
28. Sessle B.J., Greenwood L.F.J. Effects of trigeminal tractotomy and of carbamazepine on single trigeminal sensory neurons in cats. J Dent Res 1975, 54(Spec No B):B201-B206.
29. Kiguchi S., Ichikawa K., Kojima M. Suppressive effects of oxcarbazepine on tooth pulp-evoked potentials recorded at the trigeminal spinal tract nucleus in cats. Clin Exp Pharmacol Physiol 2001, 28:169-175.
30. Gilron I., Flatters S.J. Gabapentin and pregabalin for the treatment of neuropathic pain: a review of laboratory and clinical evidence. Pain Res Management 2006, 11(suppl A):16A-29A.
31. Tremont-Lukats I.W., Megeff C., Backonja M.M. Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy. Drugs 2000, 60:1029-1052.
32. Bunch S.E. Hepatotoxicity associated with pharmacologic agents in dogs and cats. Vet Clin North Am Small Anim Pract 1993, 23:659-670.
33. Cochrane S.M., Parent J.M., Black W.D., Allen D.G., Lumsden J.H. Pharmacokinetics of phenobarbital in the cat following multiple oral administration. Can J Vet Res 1990, 54:309-312.
34. Center S.A., Elston T.H., Rowland P.H., et al. Fulminant hepatic failure associated with oral administration of diazepam in 11 cats. J Am Vet Med Assoc 1996, 209:618-625.
35. Hannah J.A., Sills G.J., Brodie M. Established and new antiepileptic drugs: an overview. Epilepsy in children and adolescents 1995, 101-129. CRC Press. 1st edn. A.P. Aldenkamp, F.E. Dreifuss, W. Renier, T.P.B.M. Suurmeijer (Eds.).
36. Zeilhofer H.U., Möhler H., Di Lio A. GABAergic analgesia: new insights from mutant mice and subtype-selective agonists. Trends Pharmacol Sci 2009, 30:397-402.
37. Hayasaki H., Sohma Y., Kanbara K., Maemura K., Kubota T., Watanabe M. A local GABAergic system within rat trigeminal ganglion cells. Eur J Neurosci 2006, 23:745-757.
38. Price T.J., Hargreaves K.M., Cervero F. Protein expression and mRNA cellular distribution of the NKCC1 cotransporter in the dorsal root and trigeminal ganglia of the rat. Brain Res 2006, 1112:146-158.
39. Kato G., Yasaka T., Katafuchi T., et al. Direct GABAergic and glycinergic inhibition of the substantia gelatinosa from the rostral ventromedial medulla revealed by in vivo patch-clamp analysis in rats. J Neurosci 2006, 26:1787-1794.
40. Enna S.J., McCarson K.E. The role of GABA in the mediation and perception of pain. Adv Pharmacol 2006, 54:1-27.
41. Prasad S., Galetta S. Trigeminal neuralgia: historical notes and current concepts. Neurologist 2009, 15:87-94.
42. Wood J.N., Boorman J.P., Okuse K., Baker M.D. Voltage-gated sodium channels and pain pathways. J Neurobio 2004, 61:55-71.
43. Siqueira S.R., Alves B., Malpartida H.M., Teixeira M.J., Siqueira J.T. Abnormal expression of voltage-gated sodium channels Nav1.7. Nav1.3 and Nav1.8 in trigeminal neuralgia. Neuroscience 2009 Aug 20, (Epub ahead of print).
44. Dib-Hajj S.D., Cummins T.R., Black J.A., Waxman S.G. From genes to pain: Na v 1.7 and human pain disorders. Trends Neurosci 2007, 30:555-563.
45. Dib-Hajj S.D., Yang Y., Waxman S.G. Genetics and molecular pathophysiology of Na(v)1.7-related pain syndromes. Adv Genet 2008, 63:85-110.
46. Estacion M., Dib-Hajj S.D., Benke P.J., et al. NaV1.7 gain-of-function mutations as a continuum: A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders. J Neurosci 2008, 28:11079-11088.
47. Martinez-Lavin M., Solano C. Dorsal root ganglia, sodium channels, and fibromyalgia sympathetic pain. Med Hypotheses 2009, 72:64-66.
48. Wang G.K., Russell C., Wang S.Y. State-dependent block of voltage-gated Na+ channels by amitriptyline via the local anesthetic receptor and its implication for neuropathic pain. Pain 2004, 110:166-174.
49. Sawyer L.S., Moon-Fanelli A.A., Dodman N.H. Psychogenic alopecia in cats: 11 cases (1993-1996). J Am Vet Med Assoc 1999, 214:71-74.
50. Chew D.J., Buffington C.A., Kendall M.S., DiBartola S.P., Woodworth B.E. Amitriptyline treatment for severe recurrent idiopathic cystitis in cats. J Am Vet Med Assoc 1998, 213:1282-1286.
51. Schwartz-Porsche D., Kaiser E. Feline epilepsy. Probl Vet Med 1989, 1:628-649.
52. Kamali F., Ball D.E., McLaughlin W.S., Seymour R.A. Phenytoin metabolism to 5-(4-hydroxyphenyl)-5-phenylhydantoin (HPPH) in man, cat and rat in vitro and in vivo, and susceptibility to phenytoin-induced gingival overgrowth. J Periodontal Res 1999, 34:145-153.
53. Krafft R.M. Trigeminal neuralgia. Am Fam Physician 2008, 77:1291-1296.
54. Guerrero-Figueroa R., Escobar-Juyo A., Caballero-García G., Blanco-Castillo I.P. The effect of gabapentin in bucco-facial allodynia. Experimental correlation of the trigeminal nerve. Rev Neurol 1999, 12:1147-1153.
55. Obermann M., Yoon M.S., Sensen K., Maschke M., Diener H.C., Katsarava Z. Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia 2008, 28:174-181.
56. Hamandi K., Sander J.W. Pregabalin: a new antiepileptic drug for refractory epilepsy. Seizure 2006, 15:73-78.
57. Smith Bailey K., Dewey C.W. The seizuring cat. Diagnostic work-up and therapy. J Feline Med Surg 2009, 11:385-394.
58. Jorns T.P., Johnston A., Zakrzewska J.M. Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia. Eur J Neurol 2009, 16:740-744.
59. Domingues R.B., Kuster G.W., Aquino C.C. Treatment of trigeminal neuralgia with low doses of topiramate. Arq Neuropsiquiatr 2007, 65:792-794.
60. Siniscalchi A., Gallelli L., Marigliano N.M., Orlando P., De Sarro G. Use of topiramate for glossodynia. Pain Med 2007, 8:531-534.